|
TO:
|
ALL PRINCIPAL INVESTIGATORS/NURSES/DATA MANAGERS
|
|
FROM:
|
REGULATORY AFFAIRS DEPARTMENT
|
|
DATE:
|
NOVEMBER 20, 2019
|
|
RE:
|
PROTOCOL NRG-GY018 – Neogenomics Holiday hours
|
Protocol Title: “A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer”
Study Chair: Ramez Eskander, M.D., (858) 822-6199; email: reskander@ucsd.edu
NeoGenomics Laboratories, the central lab for MMR and PD-L1 IHC testing, will be closed the following days:
Thanksgiving Day Nov 28 2019
Christmas Day Dec 25 2019
New Year’s Eve Dec 31 2019
New Year’s Day Jan 01 2020
Please schedule your shipments accordingly.
| 
